Navigation Links
Sinovac Reports Unaudited Third Quarter 2009 Financial Results
Date:11/15/2009

1,443,834 811,901 2,753,009 2,408,745 $133,176 (2008- $16,829) for three months and $261,861 (2008- $147,958) for nine months in government research grants Depreciation of property, plant and equipment and amortization of licenses and permits 179,962 178,404 511,835 526,117 Total operating expenses 5,143,773 4,782,221 15,192,723 16,343,314 Operating income 12,405,217 2,312,588 23,730,137 12,473,120 Interest and financing expenses (246,036) (189,935) (571,349) (747,496) Interest income and other income (expenses) 77,300 58,456 243,451 (36,685) Income before income taxes and non-controlling interest 12,236,481 2,181,109 23,402,239 11,688,939 Income taxes recovery (expense) - Current (3,230,985) (1,005,174) (5,026,902) (4,229,613) - Deferred (551,478) 94,028 (1,399,428) 991,461 Consolidated net income for the period 8,454,018 1,269,963 16,975,909 8,450,787 Less: net income attributable to non-controlling interest (3,228,659) (530,084) (5,917,215) (2,814,703) Net income attributable to the stockholders $5,225,359 $739,879 $11,058,694 $5,636,084 Net income for the period $8,454,018 1,269,963 16,975,909 8,450,787 Other comprehensive income Foreign currency translation adjustment 64,108 33,637 90,728 2,358,956 Total comprehensive income 8,518,126 1,303,600 17,066,637 10,809,743 Less: comprehensive income attributable to non-controlling interest 3,229,599 522,960 5,9
'/>"/>
SOURCE Sinovac Biotech Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
2. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
3. Sinovac to Present at 2009 UBS Global Life Sciences Conference
4. Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
5. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
6. Sinovac Obtains Production License for H1N1 Vaccine
7. Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
8. Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
9. Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
10. Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
11. Sinovac Adjourns 2008 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Ames, IA (PRWEB) April 16, 2015 ... (CAST) announces that the prestigious 2015 Borlaug CAST ... honored faculty member at Tuskegee University in Alabama. ... by written material; public presentations; and/or the use ... excels in all three areas. As a specialist ...
(Date:4/16/2015)... , April 16, 2015 /CNW/ - Bioenterprise Corporation is pleased ... office in Charlottetown , PEI.  Bioenterprise ... Edward Island ADAPT Council for the commercialization of agricultural ... to working with PEI ADAPT.  They have been at ... than a decade," explains Dave Smardon , President ...
(Date:4/16/2015)... April 16, 2015  Scientists from Cleave Biosciences will ... the Horizon," at the American Association for Cancer Research ... on Sunday, April 19, 2015 from 3:15pm to ... of Biology, will present new in vivo and mechanism ... inhibitor of p97, a critical enzyme that controls various ...
(Date:4/16/2015)... MENLO PARK, Calif. , April 16, 2015 /PRNewswire/ ... the Company), a biopharmaceutical company focused on developing and ... today announced that the Mayo Clinic Cancer Center ... for the ongoing, multicenter Phase I/II study of VAL-083 ... common and deadly form of human brain cancer. ...
Breaking Biology Technology:The 2015 Borlaug CAST Communication Award Goes to Channapatna Prakash 2Bioenterprise Corporation Expands into the Maritimes 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5
... in a suit, wrinkles are almost never welcome, but two papers ... some perspective on what determines their size and shape in soft ... Amherst explore how wrinkles in a sheet adapt to an edge ... film of common plastic (polystyrene) on water and compress the sheet ...
... MADISON, Wis. , July 15 Virent Energy Systems, Inc. ... Officer and Shell executive, David Jacober , has been elected to ... , , ... Lands, End, the international apparel retailer.  She also served as CFO of ...
... , LAS VEGAS , ... , , IGEN ... assist the Board of Directors for IGEN Networks Corp. Dr Guy and Mr Celiberti,s appointments as ... , , ...
Cached Biology Technology:Virent Announces New Leadership and Board Appointments 2Virent Announces New Leadership and Board Appointments 3IGEN Networks announce the appointment of two new members to the Advisory Board 2IGEN Networks announce the appointment of two new members to the Advisory Board 3IGEN Networks announce the appointment of two new members to the Advisory Board 4
(Date:4/6/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM ... NXT-ID introduces a new revolutionary method and system ... use of miniature antenna modules for multiple purposes ...
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... supporting a harmful effect of exercise on joints in the ... review of studies published in this month,s issue of the ... popular leisure-time activity in many countries throughout the Western world ... It is widely promoted in as being beneficial for weight ...
... leading provider of,embedded speech solutions today announced the ... AG, according to SVOX CEO Volker Jantzen.,SVOX has ... developed,over 25 years, including the SpeechAdvance(TM) speech recognition ... majority of the Professional,Speech Processing Group,s employees will ...
... Most people know that too much sodium from foods can ... trying to lower their blood pressure should also boost their ... Researchers found that the ratio of sodium-to-potassium in subjects, ... sodium or potassium alone. "There isn,t as much ...
Cached Biology News:SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2Cutting salt isn't the only way to reduce blood pressure 2
... be able to handle larger sample volumes, automate ... as interface with telemetry systems. The AccuSampler ... dogs, pigs, and primates. The system may ... the computer can be located outside the animal ...
The new Silencer siRNA Starter Kit is perfect for researchers new to RNAi. It provides all of the reagents, protocols, and instructions necessary to get underway with siRNA transfection and ensure su...
... A key to successful cell culture ... nutrient composition during the process, and make ... the composition. Nova BioProfile Chemistry Analyzers provide ... gases in cell culture and fermentation media. ...
... Testing Laboratory (RTL) can provide you ... years. ,,Microbial method development and validation ... the conditions of your GMP manufacturing ... products,,We offer a full spectrum of ...
Biology Products: